This inventor holds 1 USPTO granted patent. Top assignee: Drexel University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fei Shen - Innovator in Antagonist Research
Introduction
Fei Shen is a notable inventor recognized for his contributions to the field of pharmacology. He is currently affiliated with Drexel University, where he engages in innovative research that has significant implications for medical science.
Latest Patents
Fei Shen holds a patent for "Substituted Pyrrolo[1,2-a]quinoxalin-4(5H)-ones as CX3CR1 Antagonists." This invention represents a critical advancement in the development of therapeutic agents targeting specific receptors in the human body.
Career Highlights
Throughout his career, Fei Shen has demonstrated a commitment to advancing scientific knowledge and improving health outcomes. His work at Drexel University has positioned him as a key figure in his research area.
Collaborations
Fei Shen has collaborated with esteemed colleagues, including Joseph M. Salvino and Xin Feng, to further enhance the impact of his research. These partnerships have fostered a collaborative environment that promotes innovation.
Conclusion
Fei Shen's contributions to the field of pharmacology through his patent and collaborative efforts underscore his role as an influential inventor. His work continues to pave the way for future advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile